Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

F. Heitz, P. Harter, E. Åvail-Lundqvist, A. Reuss, P. Pautier, G. Cormio, N. Colombo, A. Reinthaller, I. Vergote, A. Poveda, P. B. Ottevanger, L. C. Hanker, A. Leminen, J. Alexandre, U. Canzler, J. Sehouli, J. Herrstedt, B. Fiane, M. Merger, A. du Bois

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiGynecologic Oncology
Vuosikerta152
Numero2
Sivut235-242
Sivumäärä8
ISSN0090-8258
DOI - pysyväislinkit
TilaJulkaistu - helmikuuta 2019
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

  • 3123 Naisten- ja lastentaudit

Lainaa tätä

Heitz, F. ; Harter, P. ; Åvail-Lundqvist, E. ; Reuss, A. ; Pautier, P. ; Cormio, G. ; Colombo, N. ; Reinthaller, A. ; Vergote, I. ; Poveda, A. ; Ottevanger, P. B. ; Hanker, L. C. ; Leminen, A. ; Alexandre, J. ; Canzler, U. ; Sehouli, J. ; Herrstedt, J. ; Fiane, B. ; Merger, M. ; du Bois, A. / Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12. Julkaisussa: Gynecologic Oncology. 2019 ; Vuosikerta 152, Nro 2. Sivut 235-242.
@article{6aa50fb0e5fc42c7b983ef83e0f2abef,
title = "Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12",
keywords = "Advanced ovarian cancer, Debulking surgery, Pre-chemotherapy imaging, Prognosis, EPITHELIAL OVARIAN, CYTOREDUCTIVE SURGERY, COMPUTED-TOMOGRAPHY, POSTOPERATIVE CT, CHEMOTHERAPY, BEVACIZUMAB, CARCINOMA, INITIATION, INTERVAL, THERAPY, 3123 Gynaecology and paediatrics",
author = "F. Heitz and P. Harter and E. {\AA}vail-Lundqvist and A. Reuss and P. Pautier and G. Cormio and N. Colombo and A. Reinthaller and I. Vergote and A. Poveda and Ottevanger, {P. B.} and Hanker, {L. C.} and A. Leminen and J. Alexandre and U. Canzler and J. Sehouli and J. Herrstedt and B. Fiane and M. Merger and {du Bois}, A.",
year = "2019",
month = "2",
doi = "10.1016/j.ygyno.2018.11.008",
language = "English",
volume = "152",
pages = "235--242",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "ACADEMIC PRESS INC ELSEVIER SCIENCE",
number = "2",

}

Heitz, F, Harter, P, Åvail-Lundqvist, E, Reuss, A, Pautier, P, Cormio, G, Colombo, N, Reinthaller, A, Vergote, I, Poveda, A, Ottevanger, PB, Hanker, LC, Leminen, A, Alexandre, J, Canzler, U, Sehouli, J, Herrstedt, J, Fiane, B, Merger, M & du Bois, A 2019, 'Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12', Gynecologic Oncology, Vuosikerta 152, Nro 2, Sivut 235-242. https://doi.org/10.1016/j.ygyno.2018.11.008

Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12. / Heitz, F.; Harter, P.; Åvail-Lundqvist, E.; Reuss, A.; Pautier, P.; Cormio, G.; Colombo, N.; Reinthaller, A.; Vergote, I.; Poveda, A.; Ottevanger, P. B.; Hanker, L. C.; Leminen, A.; Alexandre, J.; Canzler, U.; Sehouli, J.; Herrstedt, J.; Fiane, B.; Merger, M.; du Bois, A.

julkaisussa: Gynecologic Oncology, Vuosikerta 152, Nro 2, 02.2019, s. 235-242.

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

TY - JOUR

T1 - Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12

AU - Heitz, F.

AU - Harter, P.

AU - Åvail-Lundqvist, E.

AU - Reuss, A.

AU - Pautier, P.

AU - Cormio, G.

AU - Colombo, N.

AU - Reinthaller, A.

AU - Vergote, I.

AU - Poveda, A.

AU - Ottevanger, P. B.

AU - Hanker, L. C.

AU - Leminen, A.

AU - Alexandre, J.

AU - Canzler, U.

AU - Sehouli, J.

AU - Herrstedt, J.

AU - Fiane, B.

AU - Merger, M.

AU - du Bois, A.

PY - 2019/2

Y1 - 2019/2

KW - Advanced ovarian cancer

KW - Debulking surgery

KW - Pre-chemotherapy imaging

KW - Prognosis

KW - EPITHELIAL OVARIAN

KW - CYTOREDUCTIVE SURGERY

KW - COMPUTED-TOMOGRAPHY

KW - POSTOPERATIVE CT

KW - CHEMOTHERAPY

KW - BEVACIZUMAB

KW - CARCINOMA

KW - INITIATION

KW - INTERVAL

KW - THERAPY

KW - 3123 Gynaecology and paediatrics

U2 - 10.1016/j.ygyno.2018.11.008

DO - 10.1016/j.ygyno.2018.11.008

M3 - Article

VL - 152

SP - 235

EP - 242

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -